US Stock MarketDetailed Quotes
PTGX Protagonist Therapeutics
- 46.460
- +4.810+11.55%
Close Nov 22 16:00 ET
- 45.930
- -0.530-1.14%
Post 20:01 ET
2.77BMarket Cap16.96P/E (TTM)
47.500High42.399Low1.32MVolume43.300Open41.650Pre Close60.63MTurnover2.78%Turnover RatioLossP/E (Static)59.60MShares48.89052wk High5.21P/B2.21BFloat Cap16.80052wk Low--Dividend TTM47.51MShs Float50.540Historical High--Div YieldTTM12.25%Amplitude4.470Historical Low45.854Avg Price1Lot Size
Protagonist Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 46.13%468.72M | 79.96%564M | 39.81%322.64M | 43.93%341.62M | 43.93%341.62M | 19.94%320.75M | 7.37%313.4M | -24.41%230.76M | -27.39%237.36M | -27.39%237.36M |
| -Cash and cash equivalents | -43.12%131.12M | 51.09%355.64M | 35.15%172.57M | 48.50%186.73M | 48.50%186.73M | 50.85%230.53M | 95.77%235.38M | 29.66%127.69M | 1.68%125.74M | 1.68%125.74M |
| -Short-term investments | 274.18%337.6M | 167.06%208.35M | 45.59%150.07M | 38.78%154.89M | 38.78%154.89M | -21.28%90.22M | -54.55%78.02M | -50.16%103.07M | -45.08%111.61M | -45.08%111.61M |
| Receivables | 4,006.15%2.67M | 2,640.00%1.37M | 588,925.49%300.4M | 19,769.23%10.33M | 19,769.23%10.33M | -89.52%65K | -98.51%50K | -99.82%51K | -99.02%52K | -99.02%52K |
| -Related party accounts receivable | --0 | 10.26%43K | 588,219.61%300.04M | 99,900.00%10M | 99,900.00%10M | --0 | --39K | --51K | -99.36%10K | -99.36%10K |
| -Other receivables | 4,006.15%2.67M | 11,963.64%1.33M | --360K | 690.48%332K | 690.48%332K | -89.52%65K | -98.46%11K | ---- | -95.69%42K | -95.69%42K |
| Prepaid assets | 32.32%5.38M | 59.26%5.56M | -8.34%4.52M | -36.01%3.63M | -36.01%3.63M | -52.51%4.07M | -61.43%3.49M | -36.27%4.93M | -33.32%5.67M | -33.32%5.67M |
| Total current assets | 46.75%476.77M | 80.14%570.93M | 166.21%627.55M | 46.28%355.58M | 46.28%355.58M | 17.45%324.88M | 4.15%316.94M | -30.97%235.74M | -28.66%243.08M | -28.66%243.08M |
| Non current assets | ||||||||||
| Net PPE | 320.62%12.3M | 264.61%12.03M | -61.56%1.5M | -53.55%2.15M | -53.55%2.15M | -45.14%2.93M | -44.86%3.3M | -40.49%3.9M | -31.30%4.63M | -31.30%4.63M |
| -Gross PPE | 116.79%19.23M | 107.62%18.73M | -15.13%7.97M | -15.15%8.38M | -15.15%8.38M | -13.89%8.87M | -15.86%9.02M | -15.22%9.39M | -10.12%9.88M | -10.12%9.88M |
| -Accumulated depreciation | -16.52%-6.93M | -17.06%-6.7M | -17.81%-6.47M | -18.65%-6.23M | -18.65%-6.23M | -19.64%-5.95M | -20.80%-5.72M | -21.37%-5.49M | -23.39%-5.25M | -23.39%-5.25M |
| Investments and advances | 5,671.28%114.56M | --31.45M | ---- | ---- | ---- | --1.99M | ---- | ---- | ---- | ---- |
| Related parties assets | --0 | 10.26%43K | 588,219.61%300.04M | 99,900.00%10M | 99,900.00%10M | --0 | --39K | --51K | -99.36%10K | -99.36%10K |
| Other non current assets | 0.00%225K | 0.00%225K | 0.00%225K | 0.00%225K | 0.00%225K | 0.00%225K | 0.00%225K | 0.00%225K | 0.00%225K | 0.00%225K |
| Total non current assets | 2,374.94%127.09M | 1,139.83%43.7M | -58.20%1.72M | -51.06%2.37M | -51.06%2.37M | -7.59%5.14M | -43.24%3.53M | -39.15%4.12M | -30.29%4.85M | -30.29%4.85M |
| Total assets | 82.98%603.86M | 91.79%614.63M | 162.35%629.28M | 44.38%357.95M | 44.38%357.95M | 16.95%330.02M | 3.21%320.47M | -31.13%239.86M | -28.69%247.93M | -28.69%247.93M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 202.08%4.22M | 34.89%6.39M | 57.82%6.87M | -78.52%871K | -78.52%871K | -71.55%1.4M | 183.37%4.74M | -40.45%4.36M | 102.04%4.06M | 102.04%4.06M |
| -accounts payable | 143.53%3.05M | -20.64%3.63M | -12.78%3.51M | -78.79%772K | -78.79%772K | -73.45%1.25M | 223.87%4.57M | -43.83%4.02M | 127.50%3.64M | 127.50%3.64M |
| -Total tax payable | --1.05M | --2.65M | --3.33M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other payable | -17.36%119K | -32.12%112K | -88.02%40K | -76.14%99K | -76.14%99K | -24.61%144K | -36.54%165K | 116.88%334K | 1.97%415K | 1.97%415K |
| Current accrued expenses | -38.10%12.47M | -38.24%9.62M | -1.30%13.99M | -36.27%12.47M | -36.27%12.47M | -18.28%20.14M | -50.72%15.57M | -52.88%14.17M | -35.15%19.57M | -35.15%19.57M |
| Current debt and capital lease obligation | -97.50%45K | ---- | -82.22%462K | -54.63%1.14M | -54.63%1.14M | -25.89%1.8M | 4.00%2.45M | 14.24%2.6M | 14.32%2.52M | 14.32%2.52M |
| -Current capital lease obligation | -97.50%45K | --0 | -82.22%462K | -54.63%1.14M | -54.63%1.14M | -25.89%1.8M | 4.00%2.45M | 14.24%2.6M | 14.32%2.52M | 14.32%2.52M |
| Current deferred liabilities | 656,433.33%19.7M | 201,140.00%20.12M | 73,209.09%16.13M | -95.65%3K | -95.65%3K | -90.63%3K | -87.50%10K | -98.08%22K | -97.24%69K | -97.24%69K |
| Current liabilities | 59.97%44.58M | 57.50%41.58M | 71.81%39.91M | -31.77%21.27M | -31.77%21.27M | -24.18%27.87M | -34.15%26.4M | -46.55%23.23M | -29.16%31.18M | -29.16%31.18M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | --10.86M | --10.97M | ---- | --0 | --0 | --0 | --0 | -84.91%462K | -68.81%1.14M | -68.81%1.14M |
| -Long term capital lease obligation | --10.86M | --10.97M | ---- | --0 | --0 | --0 | --0 | -84.91%462K | -68.81%1.14M | -68.81%1.14M |
| Non current deferred liabilities | --16.51M | --20.76M | --28.92M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total non current liabilities | --27.36M | --31.73M | 6,160.17%28.92M | --0 | --0 | --0 | --0 | -84.91%462K | -68.81%1.14M | -68.81%1.14M |
| Total liabilities | 158.16%71.94M | 177.69%73.31M | 190.54%68.83M | -34.18%21.27M | -34.18%21.27M | -27.73%27.87M | -37.94%26.4M | -49.07%23.69M | -32.21%32.32M | -32.21%32.32M |
| Shareholders'equity | ||||||||||
| Share capital | 0.00%1K | 0.00%1K | 0.00%1K | --1K | --1K | --1K | --1K | --1K | --0 | --0 |
| -common stock | 0.00%1K | 0.00%1K | 0.00%1K | --1K | --1K | --1K | --1K | --1K | --0 | --0 |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | 26.57%-472.2M | 27.91%-438.99M | 28.42%-408.37M | -14.71%-615.71M | -14.71%-615.71M | -27.95%-643.05M | -29.20%-608.94M | -32.58%-570.48M | -31.12%-536.76M | -31.12%-536.76M |
| Paid-in capital | 6.07%1B | 8.56%980.56M | 23.17%969.04M | 26.54%952.49M | 26.54%952.49M | 26.61%945.36M | 22.05%903.21M | 7.40%786.77M | 6.06%752.72M | 6.06%752.72M |
| Gains losses not affecting retained earnings | 885.88%1.34M | -25.76%-249K | -87.70%-229K | 70.75%-105K | 70.75%-105K | 64.58%-170K | 72.50%-198K | 74.15%-122K | -20.07%-359K | -20.07%-359K |
| Total stockholders'equity | 76.04%531.92M | 84.08%541.32M | 159.26%560.44M | 56.15%336.68M | 56.15%336.68M | 24.03%302.15M | 9.74%294.07M | -28.37%216.17M | -28.14%215.61M | -28.14%215.61M |
| Total equity | 76.04%531.92M | 84.08%541.32M | 159.26%560.44M | 56.15%336.68M | 56.15%336.68M | 24.03%302.15M | 9.74%294.07M | -28.37%216.17M | -28.14%215.61M | -28.14%215.61M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
